CHRW Stock Tickeron detected bearish Stock Pattern: Triangle Ascending CHRW on October 30, 2024, netting in a 0.90% gain over 2 weeks

GET DAILY SIGNALS

Get AI intraday signals

CHRW - C.H. Robinson Worldwide

Ticker: CHRW

Company: C.H. Robinson Worldwide

Gain from shortening: +0.9%

Confirmed: 10/30/24

Succeeded: 10/30/24

Total length: 14 days

CHRW in -1.33% downward trend, declining for three consecutive days on November 15, 2024

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CHRW declined for three days, in of 263 cases, the price declined further within the following month. The odds of a continued downward trend are .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 07, 2024. You may want to consider a long position or call options on CHRW as a result. In of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CHRW just turned positive on November 11, 2024. Looking at past instances where CHRW's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

CHRW moved above its 50-day moving average on November 06, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CHRW advanced for three days, in of 343 cases, the price rose further within the following month. The odds of a continued upward trend are .

CHRW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 274 cases where CHRW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CHRW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.050) is normal, around the industry mean (20.237). P/E Ratio (26.963) is within average values for comparable stocks, (22.262). Projected Growth (PEG Ratio) (1.608) is also within normal values, averaging (10.503). Dividend Yield (0.033) settles around the average of (0.037) among similar stocks. P/S Ratio (0.499) is also within normal values, averaging (1.287).